No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

focusing on key genes linked to non-small cell lung cancer (NSCLC). Advt The study found that adenocarcinoma was the most ...

Mumbai, Maharashtra, India Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 ...

Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

A chemotherapy-free regimen of neoadjuvant nivolumab (Opdivo) with or without ipilimumab (Yervoy) induced immune activation ...

Pyxis Oncology shares dropped 40% after phase 1 data on PYX-201 for solid tumors, as one participant death raises concern.

The FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors. The FDA granted ...

Calidi Biotherapeutics, Inc. recently disclosed information revealing the latest advancements in its targeted antitumor virotherapies. The company’s press release, titled “Calidi Biotherapeutics ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

particularly PM2.5 (particulate matter smaller than 2.5 microns), as a Group 1 carcinogen that causes lung cancer. Cells in ...